Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain
NCT03891264
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class
Stopped
Funding obtained to do a larger placebo-controlled trial
Conditions
Back Pain, Low
Interventions
DRUG:
Cannabidiol
Sponsor
Massachusetts General Hospital